IPCALAB.NS

Ipca Laboratories Limited [IPCALAB.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

IPCALAB.NS Stock Summary

Top 10 Correlated ETFs

IPCALAB.NS


Top 10 Correlated Stocks

IPCALAB.NS


In the News

IPCALAB.NS Financial details

Company Rating
Buy
Market Cap
339.71B
Income
5.64B
Revenue
71.86B
Book val./share
-
Cash/share
-
Dividend
2
Dividend %
0.18%
Employees
16.17K
Optionable
No
Shortable
Yes
Earnings
27 May 2024
P/E
57.54
Forward P/E
35.41
PEG
-15.91
P/S
4.24
P/B
4.61
P/C
-
P/FCF
-
Quick Ratio
1.04
Current Ratio
2.13
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
22.25
EPS next Y
37.49
EPS next Q
-
EPS this Y
-46.69%
EPS next Y
68.51%
EPS next 5Y
117.91%
EPS last 5Y
1.08%
Revenue last 5Y
11.08%
Revenue Q/Q
0.93%
EPS Q/Q
23.95%
-
-
-
-
SMA20
9.46%
SMA50
17.29%
SMA100
22.38%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
16%
ROC
0.1%
Gross Margin
65%
Oper. Margin
13%
Profit Margin
7%
Payout
-
Shs Outstand
253.7M
Shs Float
127.36M
-
-
-
-
Target Price
-
52W Range
669.8-1348.1
52W High
-1.51%
52W Low
+98.45%
RSI
70
Rel Volume
0.79
Avg Volume
563.32K
Volume
442.83K
Perf Week
8.44%
Perf Month
11.73%
Perf Quarter
41.86%
Perf Half Y
38.42%
-
-
-
-
Beta
0.23
-
-
Volatility
20.59%, 58.25%
Prev Close
-0.85%
Price
1327.65
Change
0.58%

IPCALAB.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
146.14180.27210.87227.29246.13
Net income per share
17.6123.9845.0134.8518.58
Operating cash flow per share
19.4822.3143.0433.7431.76
Free cash flow per share
12.3410.228.7714.8612.27
Cash per share
14.7116.5229.9153.5589.67
Book value per share
123.58143.44185.63216.47230.27
Tangible book value per share
115.33136.12179.86210.77225.38
Share holders equity per share
123.58143.44185.63216.47230.27
Interest debt per share
19.1320.4310.8232.160.18
Market cap
122.89B176.04B241.09B270.39B205.59B
Enterprise value
124.72B180.46B242.09B275.71B207.82B
P/E ratio
27.6329.0321.1530.5843.62
Price to sales ratio
3.333.864.514.693.29
POCF ratio
24.9631.222.1231.5925.51
PFCF ratio
39.4268.2433.0971.766.03
P/B Ratio
3.944.855.134.923.52
PTB ratio
3.944.855.134.923.52
EV to sales
3.383.964.534.783.33
Enterprise value over EBITDA
16.8218.415.0520.119.75
EV to operating cash flow
25.3431.9822.2132.2125.79
EV to free cash flow
40.0169.9533.2373.1166.75
Earnings yield
0.040.030.050.030.02
Free cash flow yield
0.030.010.030.010.02
Debt to equity
0.150.140.060.150.25
Debt to assets
0.10.10.040.110.17
Net debt to EBITDA
0.250.450.060.390.21
Current ratio
2.172.153.033.042.87
Interest coverage
29.0446.85152.68146.2815.44
Income quality
0.90.760.790.751.08
Dividend Yield
00.01000
Payout ratio
0.030.20.090.110.22
Sales general and administrative to revenue
0.020.010.020.010.01
Research and developement to revenue
0.010.010.010.010.01
Intangibles to total assets
0.050.040.030.030.02
Capex to operating cash flow
-0.37-0.54-0.33-0.56-0.61
Capex to revenue
-0.05-0.07-0.07-0.08-0.08
Capex to depreciation
-0.99-1.46-1.73-2.06-1.89
Stock based compensation to revenue
00000
Graham number
221.26278.18433.58411.97310.24
ROIC
0.120.150.220.130.06
Return on tangible assets
0.10.120.190.120.06
Graham Net
7.6811.7140.0845.1646.5
Working capital
12.8B15.29B23.04B29.91B33.83B
Tangible asset value
29.14B34.42B45.55B53.47B57.18B
Net current asset value
9.65B12.37B20.85B23.87B24.78B
Invested capital
0.150.140.060.150.25
Average receivables
8.89B10.23B10.98B11.6B11.15B
Average payables
4.74B5.67B6.38B6.12B5.41B
Average inventory
9.77B11.98B14.59B17.26B18.01B
Days sales outstanding
92.1589.1774.0278.3358
Days payables outstanding
148.31130.26134.9596.6683.09
Days of inventory on hand
303.37282.61323.08322.02275.88
Receivables turnover
3.964.094.934.666.29
Payables turnover
2.462.82.73.784.39
Inventory turnover
1.21.291.131.131.32
ROE
0.140.170.240.160.08
Capex per share
-7.15-12.11-14.27-18.88-19.49

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
60.9359.662.680.280.91
Net income per share
4.253.026.425.727.09
Operating cash flow per share
5.255.485.467.127.84
Free cash flow per share
5.255.485.467.127.84
Cash per share
51.189.6985.840.90
Book value per share
230.91230.33233.24242.460
Tangible book value per share
0225.450288.410
Share holders equity per share
230.91230.33233.24242.460
Interest debt per share
0.4359.131.2480.111.32
Market cap
213.93B205.53B188.4B237.28B283.99B
Enterprise value
226.89B207.77B210.16B252.82B283.99B
P/E ratio
49.5967.1528.9340.8939.47
Price to sales ratio
13.8413.611.8711.6713.83
POCF ratio
160.68147.78135.99131.33142.71
PFCF ratio
160.68147.78135.99131.33142.71
P/B Ratio
3.653.523.183.860
PTB ratio
3.653.523.183.860
EV to sales
14.6813.7413.2412.4313.83
Enterprise value over EBITDA
91.9595.5659.6270.2680.27
EV to operating cash flow
170.42149.39151.69139.93142.71
EV to free cash flow
170.42149.39151.69139.93142.71
Earnings yield
0.0100.010.010.01
Free cash flow yield
0.010.010.010.010.01
Debt to equity
00.2500.320
Debt to assets
00.1700.170
Net debt to EBITDA
5.251.036.174.320
Current ratio
02.8702.130
Interest coverage
16.628.027.66.117.61
Income quality
1.231.820.851.251.11
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00.1000
Intangibles to total assets
00.0200.020
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
148.6125.04183.55176.650
ROIC
0.020.010.030.020
Return on tangible assets
00.0100.010
Graham Net
51.146.5185.8-9.240
Working capital
12.97B33.83B21.76B30.33B0
Tangible asset value
057.18B073.14B0
Net current asset value
12.97B24.78B21.76B18.97B0
Invested capital
00.2500.320
Average receivables
5.58B4.96B4.96B8.84B8.84B
Average payables
2.88B2.63B2.63B3.98B3.98B
Average inventory
9.12B8.72B8.72B12.25B12.25B
Days sales outstanding
059.08078.250
Days payables outstanding
079.930105.610
Days of inventory on hand
0265.410325.460
Receivables turnover
01.5201.150
Payables turnover
01.1300.850
Inventory turnover
00.3400.280
ROE
0.020.010.030.020
Capex per share
00000

IPCALAB.NS Frequently Asked Questions

What is Ipca Laboratories Limited stock symbol ?

Ipca Laboratories Limited is a IN stock and trading under the symbol IPCALAB.NS

What is Ipca Laboratories Limited stock quote today ?

Ipca Laboratories Limited stock price is $1327.65 today.

Is Ipca Laboratories Limited stock public?

Yes, Ipca Laboratories Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap